Open Access. Powered by Scholars. Published by Universities.®
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Microbiology
Characterization Of The Function And Regulation Of The Hmpv Phosphoprotein, Rachel Thompson
Characterization Of The Function And Regulation Of The Hmpv Phosphoprotein, Rachel Thompson
Theses and Dissertations--Molecular and Cellular Biochemistry
Human metapneumovirus (HMPV) is a non-segmented, negative strand RNA virus (NNSV) that frequently causes respiratory tract infections in infants, the elderly, and the immunocompromised. Despite the initial identification of HMPV in 2001, there are currently no FDA approved antivirals or vaccines available. Therefore, understanding the mechanism of HMPV replication is critical for the identification of novel therapeutic targets. A key feature in the replication cycle of HMPV and other NNSVs is the formation of membrane-less, liquid-like replication and transcription centers in the cytosol termed inclusion bodies (IBs). Recent work on NNSV IBs suggests they display characteristics of biomolecular condensates formed …
Entry And Replication Of Negative-Strand Rna Viruses, Kerri Boggs
Entry And Replication Of Negative-Strand Rna Viruses, Kerri Boggs
Theses and Dissertations--Molecular and Cellular Biochemistry
Hendra virus (HeV) and human metapneumovirus (HMPV) are negative-sense, singled-stranded RNA viruses. The paramyxovirus HeV is classified as a biosafety level 4 pathogen due to its high fatality rate and the lack of a human vaccine or antiviral treatment. HMPV is a widespread pneumovirus that causes respiratory tract infections which are particularly dangerous for young children, immunocompromised individuals, and the elderly. Like HeV, no vaccines or therapies are available to combat HMPV infections. These viruses fuse their lipid envelopes with a cell to initiate infection. Blocking cell entry is a promising approach for antiviral development, and many vaccines are designed …
Inhibition Of Human Metapneumovirus Binding To Heparan Sulfate Blocks Infection In Human Lung Cells And Airway Tissues, Edita M. Klimyte, Stacy E. Smith, Pasqua Oreste, David Lembo, Rebecca Ellis Dutch
Inhibition Of Human Metapneumovirus Binding To Heparan Sulfate Blocks Infection In Human Lung Cells And Airway Tissues, Edita M. Klimyte, Stacy E. Smith, Pasqua Oreste, David Lembo, Rebecca Ellis Dutch
Molecular and Cellular Biochemistry Faculty Publications
Human metapneumovirus (HMPV), a recently discovered paramyxovirus, infects nearly 100% of the world population and causes severe respiratory disease in infants, the elderly, and immunocompromised patients. We previously showed that HMPV binds heparan sulfate proteoglycans (HSPGs) and that HMPV binding requires only the viral fusion (F) protein. To characterize the features of this interaction critical for HMPV binding and the role of this interaction in infection in relevant models, we utilized sulfated polysaccharides, heparan sulfate mimetics, and occluding compounds. Iota-carrageenan demonstrated potent anti-HMPV activity by inhibiting binding to lung cells mediated by the F protein. Furthermore, analysis of a minilibrary …